Benign Heme Trials

Trial No.: BMS CA209-274

Trial Name:

A Phase 3 Randomized, Double-Blind, Multi-Center Study of Adjuvant Nivolumab Versus Placebo in Subjects with High Risk Invasive Urothelial Carcinoma

Fort Wayne North Office
(260) 484-8830
11143 Parkview Plaza Drive, Suite 100
Fort Wayne, Indiana 46845

Fort Wayne South Office
(260) 436-0800
7910 West Jefferson Boulevard, Suite 108
Fort Wayne, Indiana 46804

©2018 Fort Wayne Medical Oncology and Hematology. All Rights Reserved.